n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
The authors claim that treatment with n−3 polyunsaturated fatty acid does not reduce the risk of heart attacks.
- :rating-4: Double-blind, placebo-controlled clinical trial
- :rating-4: Decent sample size: 1383 events; 11200 patients
- :rating-4: Claimed power: 90%
- :rating-4: Detailed results, confidence intervals are provided
- :rating-4: I found the protocol here, but it’s in Italian.
- :rating-2: I’ve not found the raw data
Discussed in Statistics Done Wrong (page 84).
Reference
“n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors” (2013) DOI: 10.1056/nejmoa1205409
@Article{d101056nejmoa1205409_2013,
title = {n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors},
volume = {368},
issn = {1533-4406},
url = {http://dx.doi.org/10.1056/NEJMoa1205409},
doi = {10.1056/nejmoa1205409},
number = {19},
journal = {New England Journal of Medicine},
publisher = {Massachusetts Medical Society},
year = {2013},
month = {may},
pages = {1800–1808}
}